BLT 0.00% 2.6¢ benitec biopharma limited

price target, page-40

  1. 3,083 Posts.
    lightbulb Created with Sketch. 46
    Benitec possesses and retains rights to all human therapeutic applications of its ddRNAi technology and is actively exploring licensing opportunities. Benitec also has an active clinical programme in AIDS Lymphoma under way with its collaborators at the City of Hope in Duarte, California.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.